By Patrick Wingrove and Bhanvi Satija (Reuters) – The U.S. Food and Drug Administration on Monday approved Pfizer’s respiratory syncytial virus (RSV) vaccine for use in women during the middle …
Topic:
pfizer’s
-
-
(Reuters) – Pfizer Inc said on Thursday its updated COVID-19 shot, which is being tested against emerging variants, showed neutralizing activity against the “Eris” subvariant in a study conducted on …
-
(Reuters) – Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc’s experimental respiratory syncytial virus (RSV) vaccine, boosting its chances of …
-
(Reuters) – The U.S. Food and Drug Administration (FDA) has approved Pfizer Inc’s next-generation vaccine to prevent pneumococcal disease in children aged six weeks to 17 years, the company said …
-
HONG KONG (Reuters) – China Meheco Group Co Ltd said on Wednesday it signed an agreement with Pfizer Inc to import and distribute the U.S. drugmaker’s oral COVID-19 treatment Paxlovid …
-
BENGALURU – Pfizer Ltd, the Indian arm of U.S. pharma giant Pfizer Inc, reported a rise in second-quarter profit on Friday, boosted by price hikes and lower input costs. Profit …
-
By Julie Steenhuysen CHICAGO (Reuters) – The U.S. National Institutes of Health’s $1 billion RECOVER Initiative has picked Pfizer Inc’s antiviral drug Paxlovid as the first treatment it will study …
-
By Deena Beasley (Reuters) – Use of Pfizer Inc’s COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health …
-
(Reuters) – Patients who experience recurrence of COVID-19 symptoms after completing treatment with Pfizer’s drug Paxlovid should isolate again for five days, the U.S. Centers for Disease Control and Prevention …
-
By Julie Steenhuysen CHICAGO – Additional reports of patients with long COVID who were helped by Pfizer Inc’s oral antiviral treatment Paxlovid offer fresh impetus for conducting clinical trials to …
-
(Reuters) – Pfizer Inc’s vaccines head Kathrin Jansen, who led the development of the U.S. drugmaker’s COVID-19 shot, has decided to retire later this year. “Over the last two years, …
-
By Julie Steenhuysen CHICAGO – Reports of two patients who found relief from long COVID after taking Pfizer Inc’s antiviral Paxlovid, including a researcher who tested it on herself, provide …
-
(Reuters) – Pfizer Inc’s newly appointed chief financial officer, David Denton, will get $1.25 million as annual base salary, the pharmaceutical giant said in a regulatory filing on Tuesday. A …
-
By Jonathan Stempel NEW YORK – A federal judge on Wednesday dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc of failing to disclose the presence of …
-
By Manas Mishra – Investors on Tuesday hope to learn Pfizer Inc’s plans for what could be a once-in-a-generation cash infusion from COVID-19 treatments and vaccines in 2022, with some …
-
By Deena Beasley – Rival antiviral pills from Pfizer Inc and Merck & Co that demonstrated efficacy in trials of adults with COVID-19 who are at high risk of serious …